Salt CompositionCefixime 50mg + Clavulanic Acid 31.25mg
You Searched
Daczim-CL P 50mg/31.25mg Tablet
Daksh Pharma Pvt. Ltd.
₹130
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Treatment of Bacterial infections
Customers also bought
More About Daczim-CL P 50mg/31.25mg Tablet
Benefits
In Treatment of Bacterial infections Daczim-CL P 50mg/31.25mg Tablet helps treat infections that are caused by bacteria. It contains two medicines, Cefixime, and Clavulanic acid. Cefixime stops the growth of infection-causing bacteria. Clavulanic Acid enhances the activity of Cefixime against the bacteria as well as reduces resistance of the bacteria to the antibiotic. This medicine usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all the infectious bacteria are killed and do not become resistant.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Daczim-CL P 50mg/31.25mg Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Daczim-CL P 50mg/31.25mg Tablet is a combination of two medicines: Cefixime and Clavulanic Acid. Cefixime is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Clavulanic Acid is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Cefixime against bacteria.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Daczim-CL P 50mg/31.25mg Tablet .
Safe when prescribed by an expert: Daczim-CL P 50mg/31.25mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Safe when prescribed by an expert: Daczim-CL P 50mg/31.25mg Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Not Safe: Daczim-CL P 50mg/31.25mg Tablet may cause side effects which could affect your ability to drive. Daczim-CL P 50mg/31.25mg Tablet may cause side effects such as allergic reactions, dizziness or fits that may make you unfit to drive.
Caution Advised: Daczim-CL P 50mg/31.25mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Daczim-CL P 50mg/31.25mg Tablet may be needed. Doctor consultation is advised.
Caution Advised: Daczim-CL P 50mg/31.25mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Daczim-CL P 50mg/31.25mg Tablet may be needed. Doctor consultation is advised.
What if I forget to take it?
If a dose of Daczim-CL P 50mg/31.25mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Plot No. 249, Daksh House, Industrial Area Phase -II, Panchkula -134109 (Haryana) India
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
